# Myleus Biotecnologia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myleus-biotecnologia

- Industry: Biopolymers
- Headquarters: Belo Horizonte, Brazil
- Website: www.myleus.com
- Latest round: Seed (Jun 1, 2014)
- Investors on record: 1

## About

Myleus Biotecnologia is a Brazilian biotechnology company focused on delivering innovative solutions to improve operational efficiencies in various applications, addressing specific challenges within its target market.Founded in 2010 in Belo Horizonte, Brazil, Myleus Biotecnologia specializes in biotechnological advancements. The company has undergone significant strategic pivots to enhance its product offerings. CEO Marcela Drummond leads the firm, which has completed two funding deals, with its most recent deal occurring on October 11, 2016. This funding round was aimed at supporting new initiatives as the company continues to evolve its operational focus.Myleus Biotecnologia’s primary offerings include a suite of innovative biotechnological solutions aimed at enhancing operational efficiency and improving user experience. The core product line focuses on biotechnological solutions tailored for businesses and individual consumers, particularly in the healthcare and pharmaceutical sectors. The products are marketed across North America, Europe, and Asia, allowing for a broad market presence that addresses the diverse needs of its clientele.Myleus Biotecnologia generates revenue through a structured model encompassing diverse transaction types tailored to its clients. Revenue primarily derives from direct sales to consumers and B2B partnerships, allowing for flexible engagement with both individual and corporate clients. Typical transactions occur through one-time purchases, with flagship products positioned at the center of these engagements. This structured pricing approach enhances customer satisfaction by providing scalable options aligned with client needs.Myleus Biotecnologia aims to launch new biotechnological products by utilizing data obtained from its previous funding round. The company plans to expand its market reach into Latin America and Europe by 2025. The venture financing raised in October 2016 will support these initiatives, allowing the firm to enhance its product development and geographic outreach.

## Funding rounds

- Seed, Jun 1, 2014 — Fundepar

## Investors

- Fundepar (https://capitalatlas.ai/funds/fundepar) — Seed